Past performance

Past performance is not a guarantee of future returns. The price of the investment may go up or down and an investor may not get back the amount originally invested.

Portfolio Manager Mikael Petersson comments Amgen’s acquisition of Nuevolution

“Amgen, the world’s largest biotech company with $100 billion in market cap, bidding for Nuevolution shows that our holding owns a very unique asset,” Mikael Petersson comments on the announcement that Amagen acquire Copenhagen-based biopharmaceutical company Nuevolution.

Read the article here

Subscribe to the latest news